Impact of resistance mutations in a context of low-level HIV viremia

被引：0
|
作者：
Wirden, M. [1 ]
Valantin, M. A. [1 ]
Tubiana, R. [1 ]
Simon, A. [1 ]
Soulie, C. [1 ]
Todesco, E. [1 ]
Katlama, C. [1 ]
Calvez, V. [1 ]
Marcelin, A. G. [1 ]
Lambert-Niclot, S. [1 ]
机构：
[1] Univ Paris 06, Hop Pitie Salpetriere, AP HP,Pierre Louis Inst Epidemiol & Publ Hlth, INSERM,UMR S 1136, F-75013 Paris, France
来源：
ANTIVIRAL THERAPY | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
96
引用
收藏
页码：A139 / A139
页数：1
相关论文
共 50 条
  • [11] HIV-1 genetics of intermittent low-level viremia
    Tobin, NH
    Wang, Y
    Learn, GH
    McKernan, JL
    Ellis, GM
    Mohan, KM
    Holte, SE
    Pawluk, DM
    Melvin, AJ
    Lewis, PL
    Heath, LM
    Beck, IA
    Naugler, WE
    Mullins, JI
    Frenkel, LM
    PEDIATRIC RESEARCH, 2003, 53 (04) : 331A - 331A
  • [12] Laboratory Report of HIV-1 Low-Level Viremia
    Alvarez, Hortensia
    Llibre, Josep M.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (02):
  • [13] HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
    Widera, Marek
    Dirks, Miriam
    Bleekmann, Barbara
    Jablonka, Robert
    Daeumer, Martin
    Walter, Hauke
    Ehret, Robert
    Verheyen, Jens
    Esser, Stefan
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2017, 206 (03) : 203 - 215
  • [14] HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
    Marek Widera
    Miriam Dirks
    Barbara Bleekmann
    Robert Jablonka
    Martin Däumer
    Hauke Walter
    Robert Ehret
    Jens Verheyen
    Stefan Esser
    Medical Microbiology and Immunology, 2017, 206 : 203 - 215
  • [15] Characteristics of drug resistance mutations in ART-experienced HIV-1 patients with low-level viremia in Zhengzhou City, China
    Liu, Jinjin
    Li, Chaofeng
    Sun, Yan
    Fu, Chaohong
    Wei, Shuguang
    Zhang, Xiaohua
    Ma, Jie
    Zhao, Qingxia
    Huo, Yuqi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [16] Drug resistance mutations in proviral DNA of HIV-infected patients with low level of viremia
    Villalobos, Camila
    Elena Ceballos, Maria
    Ferres, Marcela
    Palma, Carlos
    JOURNAL OF CLINICAL VIROLOGY, 2020, 132
  • [17] Natural history of patients with low-level HIV viremia on antiretroviral therapy
    Lo Re, V
    Gasink, L
    Kostman, JR
    Leonard, D
    Gross, R
    AIDS PATIENT CARE AND STDS, 2004, 18 (08) : 436 - 442
  • [18] Efficacy of genotypic drug resistance testing in patients with low-level plasma HIV-1 viremia
    Parczewski, Milosz
    Leszczyszyn-Pynka, Magdalena
    Witak-Jedra, Magdalena
    Maciejewska, Katarzyna
    Urbanska, Anna
    HIV & AIDS REVIEW, 2015, 14 (03): : 80 - 83
  • [19] Consequences of low-level viremia among women with HIV in the United States
    Aldredge, Amalia
    Mehta, C. Christina
    Lahiri, Cecile D.
    Schneider, Michael F.
    Alcaide, Maria L.
    Anastos, Kathryn
    Plankey, Michael
    French, Audrey L.
    Floris-Moore, Michelle
    Tien, Phyllis C.
    Dionne, Jodie
    Dehovitz, Jack
    Collins, Lauren F.
    Sheth, Anandi N.
    AIDS, 2024, 38 (13) : 1829 - 1838
  • [20] Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients
    Vandenhende, Marie-Anne
    Ingle, Suzanne
    May, Margaret
    Chene, Genevieve
    Zangerle, Robert
    Van Sighem, Ard
    Gill, M. John
    Schwarze-Zander, Carolynne
    Hernandez-Novoa, Beatriz
    Obel, Niels
    Kirk, Ole
    Abgrall, Sophie
    Guest, Jodie
    Samji, Hasina
    Monforte, Antonella D'Arminio
    Llibre, Josep M.
    Smith, Colette
    Cavassini, Matthias
    Burkholder, Greer A.
    Shepherd, Bryan
    Crane, Heidi M.
    Sterne, Jonathan
    Morlat, Philippe
    AIDS, 2015, 29 (03) : 373 - 383
12345